Search Results - "ICHIKURA, Daisuke"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Safety of immune checkpoint inhibitors in non-small-cell lung cancer patients with idiopathic interstitial pneumonia: a matched case–control study by Ichimura, Takenori, Hinata, Miwa, Ichikura, Daisuke, Suzuki, Shinya

    Published in Cancer chemotherapy and pharmacology (01-01-2022)
    “…Purpose The immune checkpoint inhibitor nivolumab is commonly used for non-small-cell lung cancer treatment. Immune checkpoint inhibitors cause immune-related…”
    Get full text
    Journal Article
  2. 2

    Prevention of vasculitis and vascular pain by side route administration of vinorelbine: A case report by Ishii, Shunichi, Ichimura, Takenori, Ichikura, Daisuke

    Published in Clinical case reports (01-05-2023)
    “…Key Clinical Message A 49‐year‐old female with non‐small‐cell lung cancer was placed on adjuvant chemotherapy with vinorelbine (25 mg/m2: Day 1.8) and…”
    Get full text
    Journal Article
  3. 3

    Thyroid dysfunction with atezolizumab plus bevacizumab after lenvatinib in hepatocellular carcinoma: A case series by Ichimura, Takenori, Ichikura, Daisuke, Hinata, Miwa, Hida, Noriko, Baba, Toshiyuki

    Published in SAGE open medical case reports (01-01-2023)
    “…Atezolizumab plus bevacizumab is the recommended first-line treatment for unresectable hepatocellular carcinoma, based on guidelines from the Barcelona Clinic…”
    Get full text
    Journal Article
  4. 4

    Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: A case series by Ichimura, Takenori, Hinata, Miwa, Ichikura, Daisuke, Suzuki, Shinya

    Published in SAGE open medical case reports (01-07-2021)
    “…There are few reports on the effectiveness of corticosteroids for immune checkpoint inhibitor-induced interstitial pneumonia in patients with a history of…”
    Get full text
    Journal Article
  5. 5

    Five cases of skin desquamation due to bevacizumab combined with docetaxel-carboplatin in ovarian cancer by Tokunaga, Megumi, Nawata, Shuichi, Komoto, Takayuki, Mathuura, Rei, Ichikura, Daisuke, Watanabe, Toru, Sasaki, Tadanori

    Published in International cancer conference journal (01-01-2023)
    “…The standard of care for ovarian cancer chemotherapy is paclitaxel-carboplatin. In Stage III and Stage IV patients, the addition of bevacizumab has been…”
    Get full text
    Journal Article
  6. 6

    Evaluation of the Tolerability of Gemcitabine and Cisplatin Combination Chemotherapy with a Small Quantity of Replacement Fluid for Biliary Tract Cancer by Ichimura, Takenori, Nawata, Shuichi, Ichikura, Daisuke, Murakami, Kaoru, Usuda, Masahiro, Kawashima, Wataru, Minemura, Atsuko, Sasaki, Tadanori

    Published in YAKUGAKU ZASSHI (01-07-2020)
    “…Cisplatin therapy induces kidney injury as a side effect. Thus, replacement fluid must be administered to prevent kidney injury. In our hospital, we use a…”
    Get full text
    Journal Article
  7. 7

    少量補液負荷の胆道がんGemcitabine+Cisplatin療法の忍容性評価 by 市村, 丈典, 縄田, 修一, 市倉, 大輔, 村上, 郁, 臼田, 昌弘, 川島, 渉, 峯村, 純子, 佐々木, 忠徳

    Published in YAKUGAKU ZASSHI (01-07-2020)
    “…「緒言」 胆道がんの治療法は, 外科的切除術により根治を期待できるが, 切除不能例や切除後再発例では, 生存期間の延長を目的にがん薬物療法が行われる. 胆道がん薬物療法は, 英国で2009年に行われた第III相臨床試験より,…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    A cross-sectional survey of methods for controling hand-foot syndrome in patients receiving capecitabine treatment by Suzuki, Shinya, Nawata, Shuichi, Inada, Yusuke, Sato, Daisuke, Kusano, Junichi, Ichikura, Daisuke, Torigoe, Kazuhiro, Ishitsuka, Kazumi, Sato, Fumiaki, Sakai, Hiroyasu, Yumoto, Tetsuro

    Published in Molecular and clinical oncology (01-10-2018)
    “…Medical personnel actively provide patients taking capecitabine with information on the items to prevent and treat hand-foot syndrome (HFS). However, they are…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15